JCR Pharmaceuticals Co., Ltd., a specialty pharmaceuticals company, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The company also develops Epoetin Alfa BS and Darbepoetin Alfa BS Injections for the treatment of renal anemia. In addition, it sells medical devices and laboratory instruments. JCR Pharmaceuticals Co., Ltd. was incorporated in 1975 and is headquartered in Ashiya, Japan.

Yutaka  Honda

Senior Corporation Officer, Executive Director of Admin Div. and Director of General Affairs & HR Planning Dept.

Katsuya  Nishino

Executive Vice President

Ryutaro  Makino

Director of Marketing Dept. & Group Manager of Product Planning - Marketing Dept. for Sales Div.

Toru  Ashida

Senior Vice President of Sales & Administration, Executive Director of Sales Division and Director

Hiroyuki  Fukuya

Director of Legal Affairs Department - Administration Division

Mr. Hiroyuki  Sonoda Ph.D.

Vice President of Research & Corporate Strategy, Executive Director of Research Division and Director

Mr. Shin  Ashida

Chairman, Chief Executive Officer & President

Yoshihiro  Ota

Director of Accounting Department & Corporate Strategy Department (Finance)

Hiroshi  Yoshimoto

Senior Advisor

Takayo  Egawa

Corporate Officer & Director of International Affairs Office

Fabricants de médicaments - généralités

JCR Pharmaceuticals Co., Ltd.

JCR Pharmaceuticals Co., Ltd. Structure de gestion

Informations sur la direction